Edition:
United States

MDxHealth SA (MDXH.BR)

MDXH.BR on Brussels Stock Exchange

5.25EUR
22 Mar 2017
Change (% chg)

€-0.14 (-2.65%)
Prev Close
€5.39
Open
€5.32
Day's High
€5.34
Day's Low
€5.17
Volume
312,677
Avg. Vol
205,290
52-wk High
€5.78
52-wk Low
€2.87

MDXH.BR

Chart for MDXH.BR

About

MDxHealth SA is a Belgium-based company that develops and commercializes epigenetic assays and service testing for cancer assessment and the personalized treatment of patients. The Company’s offerings are structured into two divisions: Clinical Molecular Diagnostics (ClinicalMDx) solutions, providing physicians with tests which... (more)

Overall

Beta: 0.81
Market Cap(Mil.): €267.05
Shares Outstanding(Mil.): 49.85
Dividend: --
Yield (%): --

Financials

  MDXH.BR Industry Sector
P/E (TTM): -- 48.48 30.07
EPS (TTM): -0.37 -- --
ROI: -37.71 -2.48 13.05
ROE: -38.80 5.24 14.20

BRIEF-MDxHealth signs agreement with Lab21 to make SelectMDX available in UK

* Signs agreement with Lab21 to make SelectMDX liquid biopsy test available in the United Kingdom Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Mar 21 2017

BRIEF-MDxHealth: SelectMDx chosen by Michigan Medicine

* Reg-SelectMDx chosen by Michigan Medicine as pre-biopsy diagnostic tool in groundbreaking us prostate cancer risk clinic Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Mar 08 2017

BRIEF-Mdxhealth signs agreement for distribution of SelectMDx throughout Central-South Italy

* Signs distribution deal to make its selectMDx for prostate cancer test available to Istituto Diagnostico Varelli's urology clients throughout Central-South Italy

Feb 23 2017

BRIEF-MDxHealth cash position at year end $30.9 mln

* FY EBITDA loss of $11.1 million improved by $2.5 million from 2015

Feb 23 2017

BRIEF-MDxHealth awarded ConfirmMDx testing contract by US VA

* MDxHealth awarded US department of Veterans Affairs (VA) contract for ConfirmMDx testing Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Feb 08 2017

BRIEF-Horizon Blue Cross Blue Shield of New Jersey issues positive coverage policy on MDxHealth's ConfirmMDx

* MDxHealth announces Horizon Blue Cross Blue Shield of New Jersey issues positive coverage policy on ConfirmMDx for Prostate Cancer test

Jan 18 2017

BRIEF-MDxHealth expects to achieve upgraded guidance for FY 2016 and appoints new CFO

* MDxHealth announces preliminary update on 2016 results and appointment of CFO

Jan 09 2017

BRIEF-Mdxhealth's AssureMDx multi-center validation study published in The Journal Of Urology

* Mdxhealth's AssureMDx multi-center validation study published in The Journal of Urology Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Nov 10 2016

BRIEF-Mdxhealth launches equity offering to raise of around 15 million euros

* Launched equity offering to raise an amount of approximately 15 million euros ($16.67 million) by means of a private placement of new shares

Nov 02 2016

BRIEF-Mdxhealth Q3 total revenues increased 122 pct to $9.1 million

* Q3 total revenues increased 122 pct to $9.1 million (Q3 2015: $4.1 million); up 45 pct from Q2 2016 ($6.3 million)

Nov 02 2016

More From Around the Web

Earnings vs. Estimates